Noncytotoxic inhibition of viral infection through eIF4F-independent suppression of translation by 4EGi-1

Journal of Virology

Volumn 85, Issue 2, 2011, Pages 853-864

  McMahon, Robert ^a   Zaborowska, Izabela ^a   Walsh, Derek ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

4EGI 1; HEAT SHOCK PROTEIN; INITIATION FACTOR 2ALPHA; INITIATION FACTOR 4F; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; TORIN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL STRESS; CELL STRUCTURE; CELL VIABILITY; CONCENTRATION (PARAMETERS); HERPES SIMPLEX VIRUS 1; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; LYSIS; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RIBOSOME; SENSITIVITY ANALYSIS; VACCINIA VIRUS; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CELL SURVIVAL; CELLS, CULTURED; EUKARYOTIC INITIATION FACTOR-2; EUKARYOTIC INITIATION FACTOR-4F; HERPESVIRUS 1, HUMAN; HUMANS; NITRO COMPOUNDS; PROTEIN BIOSYNTHESIS; THIAZOLES; VACCINIA VIRUS; VIRUS ACTIVATION; VIRUS REPLICATION;

EUKARYOTA; HERPESVIRIDAE; POXVIRIDAE;

EID: 78650638897     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01873-10     Document Type: Article

References (52)

1. Arias, C., D. Walsh, J. Harbell, A. C. Wilson, and I. Mohr. 2009. Activation of host translational control pathways by a viral developmental switch. PLoS Pathog. 5:e1000334.
2. Beere, H. M., D. B. Wolf, K. Cain, D. D. Mosser, A. Mahboubi, T. Kuwana, P. Tailor, R. I. Morimoto, G. M. Cohen, and D. R. Green. 2000. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat. Cell Biol. 2:469-475.
3. Castelló, A., A. Quintas, E. G. Sánchez, P. Sabina, M. Nogal, L. Carrasco, and Y. Revilla. 2009. Regulation of host translational machinery by African swine fever virus. PLoS Pathog. 5:e1000562.
4. Coldwell, M. J., and S. J. Morley. 2006. Specific isoforms of translation initiation factor 4GI show differences in translational activity. Mol. Cell. Biol. 26:8448-8460.
5. De Benedetti, A., and R. E. Rhoads. 1990. Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology. Proc. Natl. Acad. Sci. U. S. A. 87:8212-8216.
6. Diaz, J. J., D. Simonin, T. Massé, P. Deviller, K. Kindbeiter, L. Denoroy, and J. J. Madjar. 1993. The herpes simplex virus type 1 US11 gene product is a phosphorylated protein found to be non-specifically associated with both ribosomal subunits. J. Gen. Virol. 74:397-406.
7. Everett, R. 2000. ICP0, a regulator of herpes simplex virus during lytic and latent infection. Bioessays 22:761-770.
8. Fan, S., Y. Li, P. Yue, F. R. Khuri, and S. Y. Sun. 2010. The eIF4E/eIF4G interaction inhibitor 4EGI-1 augments TRAIL-mediated apoptosis through c-FLIP down-regulation and DR5 induction independent of inhibition of cap-dependent protein translation. Neoplasia 12:346-356.
9. Feng, P., D. N. Everly, Jr., and G. S. Read. 2005. mRNA decay during herpes simplex virus (HSV) infections: protein-protein interactions involving the HSV virion host shutoff protein and translation factors eIF4H and eIF4A. J. Virol. 79:9651-9664.
10. Fontaine-Rodriguez, E. C., T. J. Taylor, M. Olesky, and D. M. Knipe. 2004. Proteomics of herpes simplex virus infected cell protein 27: association with translation initiation factors. Virology 330:487-492.
11. Fukuchi-Shimogori, T., I. Ishii, K. Kashiwagi, H. Mashiba, H. Ekimoto, and K. Igarashi. 1997. Malignant transformation by overproduction of translation initiation factor eIF4G. Cancer Res. 57:5041-5044.
12. Gingras, A. C., S. P. Gygi, B. Raught, R. D. Polakiewicz, R. T. Abraham, M. F. Hoekstra, R. Aebersold, and N. Sonenberg. 1999. Regulation of 4EBP1 phosphorylation: a novel two-step mechanism. Genes Dev. 13:1422-1437.
13. Graff, J. R., B. W. Konicek, R. L. Lynch, C. A. Dumstorf, M. S. Dowless, A. M. McNulty, S. H. Parsons, L. H. Brail, B. M. Colligan, J. W. Koop, B. M. Hurst, J. A. Deddens, B. L. Neubauer, L. F. Stancato, H. W. Carter, L. E. Douglass, and J. H. Carter. 2009. eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival. Cancer Res. 69:3866-3873.
14. Graff, J. R., B. W. Konicek, T. M. Vincent, R. L. Lynch, D. Monteith, S. N. Weir, P. Schwier, A. Capen, R. L. Goode, M. S. Dowless, Y. Chen, H. Zhang, S. Sissons, K. Cox, A. M. McNulty, S. H. Parsons, T. Wang, L. Sams, S. Geeganage, L. E. Douglass, B. L. Neubauer, N. M. Dean, K. Blanchard, J. Shou, L. F. Stancato, J. H. Carter, and E. G. Marcusson. 2007. Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity. J. Clin. Invest. 117:2638-2648.
15. Hinnebusch, A. G. 2006. eIF3: a versatile scaffold for translation initiation complexes. Trends Biochem. Sci. 31:553-562.
16. Hinton, T. M., M. J. Coldwell, G. A. Carpenter, S. J. Morley, and V. M. Pain. 2007. Functional analysis of individual binding activities of the scaffold protein eIF4G. J. Biol. Chem. 282:1695-1708.
17. Imataka, H., A. Gradi, and N. Sonenberg. 1998. A newly identified Nterminal amino acid sequence of human eIF4G binds poly(A)-binding protein and functions in poly(A)-dependent translation. EMBO J. 17:7480-7489.
18. Joshi-Barve, S., A. De Benedetti, and R. E. Rhoads. 1992. Preferential translation of heat shock mRNAs in HeLa cells deficient in protein synthesis initiation factors eIF-4E and eIF-4 gamma. J. Biol. Chem. 267:21038-21043.
19. Kahvejian, A., Y. V. Svitkin, R. Sukarieh, M. N. M'Boutchou, and N. Sonenberg. 2005. Mammalian poly(A)-binding protein is a eukaryotic translation initiation factor, which acts via multiple mechanisms. Genes Dev. 19:104-113.
20. Khaleghpour, K., S. Pyronnet, A. C. Gingras, and N. Sonenberg. 1999. Translational homeostasis: eukaryotic translation initiation factor 4E control of 4E-binding protein 1 and p70 S6 kinase activities. Mol. Cell. Biol. 19: 4302-4310.
21. Kimball, S. R., A. N. Do, L. Kutzler, D. R. Cavener, and L. S. Jefferson. 2008.Rapid turnover of the mTOR complex 1 (mTORC1) repressor REDD1 and activation of mTORC1 signaling following inhibition of protein synthesis. J. Biol. Chem. 283:3465-3475.
22. Kudchodkar, S. B., Y. Yu, T. G. Maguire, and J. C. Alwine. 2004. Human cytomegalovirus infection induces rapamycin-insensitive phosphorylation of downstream effectors of mTOR kinase. J. Virol. 78:11030-11039.
23. Larralde, O., R. W. Smith, G. S. Wilkie, P. Malik, N. K. Gray, and J. B.Clements. 2006. Direct stimulation of translation by the multifunctional herpesvirus ICP27 protein. J. Virol. 80:1588-1591.
24. Masutani, M., N. Sonenberg, S. Yokoyama, and H. Imataka. 2007. Reconstitution reveals the functional core of mammalian eIF3. EMBO J. 26:3373-3383.
25. McMahon, R., and D. Walsh. 2008. Efficient quiescent infection of normal human diploid fibroblasts with wild-type herpes simplex virus type 1. J. Virol. 82:10218-10230.
26. Moerke, N. J., H. Aktas, H. Chen, S. Cantel, M. Y. Reibarkh, A. Fahmy, J. D. Gross, A. Degterev, J. Yuan, M. Chorev, J. A. Halperin, and G. Wagner. 2007. Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G. Cell 128:257-267.
27. Mohr, I. 2006. Phosphorylation and dephosphorylation events that regulate viral mRNA translation. Virus Res. 119:89-99.
28. Mokas, S., J. R. Mills, C. Garreau, M. J. Fournier, F. Robert, P. Arya, R. J. Kaufman, J. Pelletier, and R. Mazroui. 2009. Uncoupling stress granule assembly and translation initiation inhibition. Mol. Biol. Cell 20:2673-2683.
29. Moorman, N. J., and T. Shenk. 2010. Rapamycin-resistant mTORC1 activity is required for herpesvirus replication. J. Virol. 84:5260-5269.
30. Moss, B. 2007. Poxviridae: the viruses and their replication, p. 2849-2883. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology. Lippincott Williams & Wilkins, Philadelphia, PA.
31. Nathan, C. O., S. Franklin, F. W. Abreo, R. Nassar, A. De Benedetti, and J. Glass. 1999. Analysis of surgical margins with the molecular marker eIF4E: a prognostic factor in patients with head and neck cancer. J. Clin. Oncol. 17:2909-2914.
32. Proud, C. G. 2005. eIF2 and the control of cell physiology. Semin. Cell Dev. Biol. 16:3-12.
33. Pyronnet, S., H. Imataka, A. C. Gingras, R. Fukunaga, T. Hunter, and N. Sonenberg. 1999. Human eukaryotic translation initiation factor 4G (eIF4G) recruits mnk1 to phosphorylate eIF4E. EMBO J. 18:270-279.
34. Ramŕez-Valle, F., S. Braunstein, J. Zavadil, S. C. Formenti, and R. J. Schneider. 2008. eIF4GI links nutrient sensing by mTOR to cell proliferation and inhibition of autophagy. J. Cell Biol. 181:293-307.
35. Rinker-Schaeffer, C. W., J. R. Graff, A. De Benedetti, S. G. Zimmer, and R. E. Rhoads. 1993. Decreasing the level of translation initiation factor 4E with antisense RNA causes reversal of ras-mediated transformation and tumorigenesis of cloned rat embryo fibroblasts. Int. J. Cancer 55:841-847.
36. Roizman, B., D. M. Knipe, and R. J. Whitley. 2007. Herpes simplex viruses, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
37. Roller, R. J., and B. Roizman. 1992. The herpes simplex virus 1 RNA binding protein US11 is a virion component and associates with ribosomal 60S subunits. J. Virol. 66:3624-3632.
38. Sarnow, P., R. C. Cevallos, and E. Jan. 2005. Takeover of host ribosomes by divergent IRES elements. Biochem. Soc. Trans. 33:1479-1482.
39. Silvera, D., S. C. Formenti, and R. J. Schneider. 2010. Translational control in cancer. Nat. Rev. Cancer 10:254-266.
40. Smith, M. R., M. Jaramillo, Y. L. Liu, T. E. Dever, W. C. Merrick, H. F. Kung, and N. Sonenberg. 1990. Translation initiation factors induce DNA synthesis and transform NIH 3T3 cells. New Biol. 2:648-654.
41. Sonenberg, N., and A. G. Hinnebusch. 2009. Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 136:731-745.
42. Tamburini, J., A. S. Green, V. Bardet, N. Chapuis, S. Park, L. Willems, M. Uzunov, N. Ifrah, F. Dreyfus, C. Lacombe, P. Mayeux, and D. Bouscary. 2009. Protein synthesis is resistant to rapamycin and constitutes a promising therapeutic target in acute myeloid leukemia. Blood 114:1618-1627.
43. Thoreen, C. C., S. A. Kang, J. W. Chang, Q. Liu, J. Zhang, Y. Gao, L. J. Reichling, T. Sim, D. M. Sabatini, and N. S. Gray. 2009. An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J. Biol. Chem. 284:8023-8032.
44. Walsh, D., C. Arias, C. Perez, D. Halladin, M. Escandon, T. Ueda, R. Watanabe-Fukunaga, R. Fukunaga, and I. Mohr. 2008. Eukaryotic translation initiation factor 4F architectural alterations accompany translation initiation factor redistribution in poxvirus-infected cells. Mol. Cell. Biol. 28: 2648-2658.
45. Walsh, D., and I. Mohr. 2006. Assembly of an active translation initiation factor complex by a viral protein. Genes Dev. 20:461-472.
46. Walsh, D., and I. Mohr. 2004. Phosphorylation of eIF4E by Mnk-1 enhances HSV-1 translation and replication in quiescent cells. Genes Dev. 18:660-672.
47. Walsh, D., C. Perez, J. Notary, and I. Mohr. 2005. Regulation of the translation initiation factor eIF4F by multiple mechanisms in human cytomegalovirus-infected cells. J. Virol. 79:8057-8064.
48. Waskiewicz, A. J., A. Flynn, C. G. Proud, and J. A. Cooper. 1997. Mitogenactivated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J. 16:1909-1920.
49. Wells, S. E., P. E. Hillner, R. D. Vale, and A. B. Sachs. 1998. Circularization of mRNA by eukaryotic translation initiation factors. Mol. Cell 2:135-140.
50. Wilson, J. E., T. V. Pestova, C. U. T. Hellen, and P. Sarnow. 2000. Initiation of protein synthesis from the A site of the ribosome. Cell 102:511-520.
51. Yueh, A., and R. J. Schneider. 2000. Translation by ribosome shunting on adenovirus and hsp70 mRNAs facilitated by complementarity to 18S rRNA. Genes Dev. 14:414-421.
52. Zaborowska, I., and D. Walsh. 2009. PI3K signaling regulates rapamycininsensitive translation initiation complex formation in vaccinia virus-infected cells. J. Virol. 83:3988-3992.